
Sign up to save your podcasts
Or


Never miss another webinar! Sign up here: https://imahealth.org/weekly-webinars/
Learn more: https://imahealth.org/spike-protein-susceptibility/
Is everyone equally at risk from COVID-19 vaccines? New IMA-backed research says no. This week, IMA Chief Scientific Officer Dr. Paul Marik is joined by Dr. James Thorp, Dr. Jack Tuszynski, and Matt Halma—three of the lead authors behind a groundbreaking study on spike protein injury.
Together, they’ll explore how the unique structure of the spike protein may affect certain tissues, how genetic and cellular factors influence susceptibility, and what this could mean for patients experiencing long-term symptoms. This conversation offers vital insights into the growing understanding of vaccine injury risk and builds on IMA’s commitment to research-driven healthcare reform. Don’t miss it!
URL: https://imahealth.org/spike-protein-susceptibility/
Keywords/Tags: spike protein susceptibility
• Donate: https://imahealth.org/donate/
• Follow: https://imahealth.org/contact/
• Webinar: https://imahealth.org/category/weekly-webinars/
• Treatment: https://imahealth.org/treatment-protocols/
• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/
About IMA (Formerly FLCCC Alliance)
The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization’s mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.
For more information about the Independent Medical Alliance, visit www.IMAhealth.org
By by the IMA (Formerly FLCCC Alliance)4.9
4747 ratings
Never miss another webinar! Sign up here: https://imahealth.org/weekly-webinars/
Learn more: https://imahealth.org/spike-protein-susceptibility/
Is everyone equally at risk from COVID-19 vaccines? New IMA-backed research says no. This week, IMA Chief Scientific Officer Dr. Paul Marik is joined by Dr. James Thorp, Dr. Jack Tuszynski, and Matt Halma—three of the lead authors behind a groundbreaking study on spike protein injury.
Together, they’ll explore how the unique structure of the spike protein may affect certain tissues, how genetic and cellular factors influence susceptibility, and what this could mean for patients experiencing long-term symptoms. This conversation offers vital insights into the growing understanding of vaccine injury risk and builds on IMA’s commitment to research-driven healthcare reform. Don’t miss it!
URL: https://imahealth.org/spike-protein-susceptibility/
Keywords/Tags: spike protein susceptibility
• Donate: https://imahealth.org/donate/
• Follow: https://imahealth.org/contact/
• Webinar: https://imahealth.org/category/weekly-webinars/
• Treatment: https://imahealth.org/treatment-protocols/
• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/
About IMA (Formerly FLCCC Alliance)
The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization’s mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.
For more information about the Independent Medical Alliance, visit www.IMAhealth.org

386 Listeners

7,214 Listeners

1,681 Listeners

1,829 Listeners

466 Listeners

805 Listeners

233 Listeners

246 Listeners

2,491 Listeners

288 Listeners

142 Listeners

1,194 Listeners

478 Listeners

118 Listeners

113 Listeners